VET Earnings

VET reported its earnings on 2026-03-04, showcasing a revenue of 329.06M against an estimate of 389.09M, resulting in a -15.43% surprise. The EPS was 0.63, surpassing the expected 0.3 by 110%. The stock experienced a -1.73% price change on the earnings day and a -0.43% change over the next five days, reflecting market reactions to the results.

Following VET's earnings announcement on 2026-03-04, the stock price moved by -1.73% on the day of the release. Over the subsequent five days, it saw a -0.43% change. Historically, VET's stock price tends to shift by an average of 2.51% in the 10 days leading up to earnings and 2.78% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate VET's annual revenue to reach 540.40M, while the EPS is projected at 0.42. These estimates reflect recent revisions, with revenue estimates revised upward by 0.36% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between VET's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.36%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, VET's stock price typically moves by 2.51% in the 10 days before its earnings and 2.78% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.42 and revenue of 540.40M.

The earnings call reveals strong financial performance with positive free cash flow and debt reduction. The Q&A section highlights optimistic guidance, well outperformance, and positive regulatory shifts. Despite minor negative revisions and unclear M&A details, the overall sentiment is positive. The increase in shareholder returns and strategic investments in high-potential regions suggest a positive outlook. Given the market cap, the stock is likely to see a positive movement of 2% to 8% over the next two weeks.